FDA 483 - Dorel Juvenile Group, Inc. - April 25, 2024

An FDA inspection of Dorel Juvenile Group, Inc. in Columbus, IN, a specification developer, revealed significant deficiencies in their quality system. Observations included inadequate maintenance of complaint files for Class II thermometers, a lack of regular management reviews of the quality system, and a failure to perform internal quality audits at defined intervals.